Elevated intravitreal interleukin-6 levels in patients with proliferative diabetic retinopathy.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Canadian Journal of Ophthalmology-journal Canadien D Ophtalmologie

• Publication date

  2006-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3129/I06-070PMID 17224958
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin (IL)-6, Interleukin (IL)-8 Levels and Cellular Composition of the Vitreous Humor in Proliferative Diabetic Retinopathy, Proliferative Vitreoretinopathy, and Traumatic Proliferative Vitreoretinopathy

  2005cited by this paper
• Endotoxin-induced uveitis in the rat

  2004cited by this paper
• Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients

  2004cited by this paper
• Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.

  2003cited by this paper
• Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema.

  2002cited by this paper
• Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy.

  2001cited by this paper
• Quantitative analysis of interleukin-6 in vitreous from patients with proliferative vitreoretinal diseases.

  2001cited by this paper
• Review: Effects of Nitric Oxide on Eye Diseases and Their Treatment

  2001cited by this paper
• Disruption of the Blood-Aqueous Barrier following Retinal Laser Photocoagulation and Cryopexy in Pigmented Rabbits

  2000cited by this paper
• Roles of cytokines in diabetic retinopathy.

  1999cited by this paper
• Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis.

  1998cited by this paper
• Clinical implications of vascular growth factors in proliferative retinopathies.

  1997cited by this paper
• Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor (*)

  1996cited by this paper
• Glucose-Dependent Interleukin 6 and Tumor Necrosis Factor Production by Human Peripheral Blood Monocytes In Vitro

  1996cited by this paper
• Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6

  1995cited by this paper
• The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.

  1995cited by this paper
• A phase I trial of intravenous interleukin-6 in patients with advanced cancer.

  1994cited by this paper
• Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy.

  1994cited by this paper
• Cytokines in human intraocular inflammation.

  1992cited by this paper
• Cytokines in the vitreous of patients with proliferative diabetic retinopathy.

  1992cited by this paper
• IL-6 increases endothelial permeability in vitro.

  1992cited by this paper
• Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration.

  1992cited by this paper
• Endotoxin-induced uveitis in the rat. The significance of intraocular interleukin-6.

  1992cited by this paper
• The biology of interleukin-6.

  1989cited by this paper
• The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases

  1948cited by this paper

• Unraveling the Role of Midkine in Proliferative Diabetic Retinopathy: Implications from Hypoxia-Induced Angiogenesis

  2025cites this paper
• Serum Albumin and Glycemic Variability Could Contribute to Diabetic Retinopathy Progression by Regulating Chronic Inflammatory Pathways

  2025cites this paper
• The Role of Th17/Treg Axis in Retinal Pathology Associated with Diabetes and Treatment Options

  2025cites this paper
• Cytokine gene polymorphism with type 2 diabetes and diabetic nephropathy in population from West India

  2024cites this paper
• Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy

  2024cites this paper
• Urinary and circulatory netrin-1 as biomarker in diabetes and its related complications: a systematic review and meta-analysis

  2023cites this paper
• Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation

  2023cites this paper
• The investigation of the effects of monosodium glutamate on healthy rats and rats with STZ‐induced diabetes

  2023cites this paper
• Diabetic Müller-Glial-Cell-Specific Il6ra Knockout Mice Exhibit Accelerated Retinal Functional Decline and Thinning of the Inner Nuclear Layer

  2023cites this paper
• Association of SDF-1 and its receptor CXCR4 polymorphisms on the susceptibility of diabetic retinopathy in the Taiwanese population

  2023cites this paper
• Blockade of interleukin-6 trans-signaling prevents mitochondrial dysfunction and cellular senescence in retinal endothelial cells.

  2023cites this paper
• Evaluation of TNF‐α and IL‐6 in saliva among diabetic retinopathy patients in East Coast Malaysia

  2022cites this paper
• Lower hydration status increased diabetic retinopathy among middle-aged adults and older adults: Results from NHANES 2005-2008

  2022cites this paper
• Neuroinflammation, Microglia and Implications for Retinal Ganglion Cell Survival and Axon Regeneration in Traumatic Optic Neuropathy

  2022cites this paper
• Targeting proliferative retinopathy: Arginase 1 limits vitreoretinal neovascularization and promotes angiogenic repair

  2022cites this paper
• Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis

  2022cites this paper
• The innate immune system in diabetic retinopathy.

  2021cites this paper
• Mesenchymal Stromal Cells Promote Retinal Vascular Repair by Modulating Sema3E and IL-17A in a Model of Ischemic Retinopathy

  2021cites this paper
• Interleukin-6 Trans-signaling: A Pathway With Therapeutic Potential for Diabetic Retinopathy

  2021cites this paper
• The Vitreous Ecosystem in Diabetic Retinopathy: Insight into the Patho-Mechanisms of Disease

  2021influential citation
• AAV-Mediated Expression of Human VEGF, TNF-α, and IL-6 Induces Retinal Pathology in Mice

  2021cites this paper
• The role of concomitant immunosuppressants in impeding the progression of diabetic retinopathy: A pilot study

  2021cites this paper
• Inflammatory mediators in diabetic retinopathy: Deriving clinicopathological correlations for potential targeted therapy

  2021cites this paper
• Level of VEGF-A and interleukin 6 in lacrimal fluid of patients with diabetic retinopathy

  2020cites this paper
• Diabetic Retinopathy and Ocular Melanoma: How Far We Are?

  2020cites this paper
• Increased circulating cytokine levels in African American women with obesity and elevated HbA1c.

  2020cites this paper
• Downregulation of Long Noncoding RNA MIAT in the Retina of Diabetic Rats with Tail-vein Injection of Human Umbilical-cord Mesenchymal Stem Cells

  2020cites this paper
• Pathophysiology of Uveitic Macular Edema

  2020cites this paper
• Interleukin-6 trans-signaling inhibition prevents oxidative stress in a mouse model of early diabetic retinopathy

  2020cites this paper
• RNA-Seq analysis reveals gene expression changes induced by IL-6 trans-signaling activation in retinal endothelial cells.

  2020cites this paper
• The role of IL-6-174 G/C polymorphism and intraocular IL-6 levels in the pathogenesis of ocular diseases: a systematic review and meta-analysis

  2020cites this paper
• Importance of the Use of Oxidative Stress Biomarkers and Inflammatory Profile in Aqueous and Vitreous Humor in Diabetic Retinopathy

  2020cites this paper
• Endothelial Dysfunction in Diabetic Retinopathy

  2020cites this paper
• Ranibizumab Alters Levels of Intraocular Soluble Cytokine Receptors in Patients with Diabetic Macular Edema

  2020cites this paper
• Serum and vitreous resistin levels in patıents with proliferative diabetic retinopathy.

  2019cites this paper
• Inhibition of interleukin‐6 trans‐signaling prevents inflammation and endothelial barrier disruption in retinal endothelial cells

  2019cites this paper
• Interleukin-6 and Diabetic Retinopathy: A Systematic Review and Meta-Analysis

  2019cites this paper
• The relationship of blood cell-associated inflammatory indices and diabetic retinopathy: a Meta-analysis and systematic review.

  2019cites this paper
• Effect of lncRNA MEG3 on retinopathy in diabetic rats through regulating Fox01 expression.

  2019cites this paper
• Anti-inflammatory cytokine and angiogenic factors levels in vitreous samples of diabetic retinopathy patients

  2018cites this paper
• Oleanolic Acids Inhibit Vascular Endothelial Growth Factor Receptor 2 Signaling in Endothelial Cells: Implication for Anti-Angiogenic Therapy

  2018cites this paper
• Potential Interplay between Hyperosmolarity and Inflammation on Retinal Pigmented Epithelium in Pathogenesis of Diabetic Retinopathy

  2018cites this paper
• Remote Ischemic Conditioning Protects Diabetic Retinopathy in Streptozotocin-induced Diabetic Rats via Anti-Inflammation and Antioxidation

  2018cites this paper
• Endothelial STAT3 Activation Increases Vascular Leakage Through Downregulating Tight Junction Proteins: Implications for Diabetic Retinopathy

  2017cites this paper
• Cytokines and growth factors in the pathogenesis of proliferative diabetic retinopathy

  2017cites this paper
• The effect of diabetes on ovaries in a rat model: the role of interleukin-33 and apoptosis

  2017cites this paper
• Therapeutic drug repositioning using personalized proteomics of liquid biopsies.

  2017cites this paper
• Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy

  2017cites this paper
• Tetrahydrobiopterin (BH4) deficiency is associated with augmented inflammation and microvascular degeneration in the retina

  2017cites this paper
• Inhibition of HIF‐1α decreases expression of pro‐inflammatory IL‐6 and TNF‐α in diabetic retinopathy

  2017influential citation
• Astragaloside Alleviates Hepatic Fibrosis Function via PAR2 Signaling Pathway in Diabetic Rats

  2017cites this paper
• Status of pro-inflammatory Marker IL-6 and Microalbuminuria in type- 2 Diabetic Nephropathy subjects

  2017cites this paper
• Neuron-derived netrin-1 and netrin-4 proteins are additional effective targets in diabetic retinopathy beyond VEGF.

  2017cites this paper
• Identification of intraocular inflammatory mediators in patients with endophthalmitis

  2016cites this paper
• Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy

  2016cites this paper
• Treatment with polyamine oxidase inhibitor reduces microglial activation and limits vascular injury in ischemic retinopathy.

  2016cites this paper
• An Evaluation of the Preventive Role of Ficus religiosa on High Fat Diet and Low Dose Streptozotocin Induced Diabetes Mellitus in Rats

  2016cites this paper
• Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications.

  2016cites this paper
• Pathophysiology and pharmacological targets of VEGF in diabetic macular edema.

  2016cites this paper
• Understanding the Role of Adiponectin in Proliferative Diabetic Retinopathy Design and Development of Therapeutic Molecules

  2015cites this paper
• Dendrobium chrysotoxum Lindl. Alleviates Diabetic Retinopathy by Preventing Retinal Inflammation and Tight Junction Protein Decrease

  2015cites this paper
• Renoprotective effect of lansoprazole in streptozotocin-induced diabetic nephropathy in wistar rats

  2015cites this paper
• Interleukin-6 concentrations in the vitreous body of patients with retinal detachment.

  2015cites this paper
• Inflammatory Cytokines in Diabetic Nephropathy

  2015cites this paper
• Diabetic Retinopathy: Vascular and Inflammatory Disease

  2015cites this paper
• Retinal neurons curb inflammation and enhance revascularization in ischemic retinopathies via proteinase-activated receptor-2.

  2015cites this paper
• Concentración de interleuquina-6 en el vítreo de pacientes con desprendimiento de retina

  2015cites this paper
• Pathophysiology and pharmacological targets of diabetic macular edema : an 1 updated review

  2014cites this paper
• Inflammation in diabetic kidney disease.

  2014cites this paper
• Effect of Adipose Tissue-Derived Inflammatory and Proangiogenic Cytokines on Proliferative Diabetic Retinopathy

  2014cites this paper
• Das therapeutische Potential der pharmakologischen Interferenz mit dem Renin-Angiotensin-System im in vitro Modell der diabetischen Retinopathie

  2014cites this paper
• Monitoring of glycation, oxidative stress and inflammation in relation to the occurrence of vascular complications in patients with type 2 diabetes mellitus.

  2014cites this paper
• Negative association of serum IL-6 and IL-17 with type-II diabetes retinopathy.

  2014cites this paper
• Effect of adipose tissue-derived inflammatory and proangiogenic cytokines on proliferative diabetic retinopathy

  2014cites this paper
• Microglia and Interleukin-1&bgr; in Ischemic Retinopathy Elicit Microvascular Degeneration Through Neuronal Semaphorin-3A

  2013cites this paper
• Modulation of pro-inflammatory responses in the retina by Neuropeptide Y : the role of NPY Y, receptor

  2013cites this paper
• Profile of intraocular tumour necrosis factor‐α and interleukin‐6 in diabetic subjects with different degrees of diabetic retinopathy

  2013cites this paper
• Inflammation and Pharmacological Treatment in Diabetic Retinopathy

  2013cites this paper
• Neuroretinal activation in diabetes mellitus

  2013cites this paper
• Evaluation of a Dipeptidyl Peptidase IV Inhibitor as a Microvascular Protector in Diabetes

  2013cites this paper
• Role of Intravitreal Inflammatory Cytokines and Angiogenic Factors in Proliferative Diabetic Retinopathy

  2012cites this paper
• MSC transplantation: a promising therapeutic strategy to manage the onset and progression of diabetic nephropathy.

  2012cites this paper
• Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.

  2012cites this paper
• The Role of Genetics and Immune Mechanisms in the Pathogenesis of Diabetic Retinopathy

  2012influential citation
• Pathophysiology Of Retina In Type Ii Diabetes Mellitus Conventional Diagnostic Parameters Versus Emerging Roles Of Growth Factors And Cytokines

  2012cites this paper
• Anti-inflammatory therapy for diabetic retinopathy.

  2011cites this paper
• Inflammation and diabetic retinal microvascular complications

  2011cites this paper
• Increased IL-6 levels are not related to NF-κB or HIF-1α transcription factors activity in the vitreous of proliferative diabetic retinopathy.

  2011cites this paper
• Effect of Some Anti-Inflammatory Drugs with and Without Antioxidant on Some Inflammatory Mediators in Diabetic Male Albino Rats

  2011cites this paper
• Inflammatory and Angiogenic Factors in the Aqueous Humor and the Relationship to Diabetic Retinopathy

  2010cites this paper
• Inflammatory mediators in diabetic retinopathy

  2010cites this paper
• Quantitative changes in serum IL-8, TNF-α and TGF-β1 levels depending on compensation stage in type 2 diabetic patients

  2009cites this paper
• Interleukin-6 as a photoreceptor neuroprotectant in an experimental model of retinal detachment.

  2008cites this paper
• Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy.

  2008cites this paper
• The role of inflammatory cytokines in diabetic nephropathy.

  2008cites this paper
• Inflammatory cystoid macular edema

  2007cites this paper
• Retinal Neurons Curb In fl ammation and Enhance Revascularization in Ischemic Retinopathies via Proteinase-Activated Receptor-2

  year unknowncites this paper